TABLE 1.
COX regression analysis of the prognostic correlation between YARS1 and BLCA.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | p Value | Hazard ratio (95% CI) | p Value | ||
| Gender | 46 | ||||
| Male | 40 | Reference | |||
| Female | 6 | 2.085 (0.768–5.657) | 0.149 | ||
| Age | 46 | 0.990 (0.948–1.034) | 0.656 | ||
| Grade | 46 | ||||
| High | 42 | Reference | |||
| Low | 4 | 1.121 (0.262–4.799) | 0.878 | ||
| Tumour size | 46 | ||||
| <5 cm | 29 | Reference | |||
| ≥5 cm | 17 | 0.708 (0.313–1.605) | 0.409 | ||
| Tumour invasion | 46 | ||||
| Yes | 4 | Reference | Reference | ||
| No | 42 | 0.306 (0.104–0.897) | 0.031 | 0.190 (0.026–1.387) | 0.101 |
| Lymph node metastasis | 46 | ||||
| Yes | 9 | Reference | Reference | ||
| No | 37 | 0.396 (0.162–0.964) | 0.041 | 2.445 (0.386–15.494) | 0.343 |
| Stage‐T | 46 | ||||
| >T2 | 25 | Reference | Reference | ||
| ≤T2 | 21 | 0.348 (0.150–0.807) | 0.014 | 2.472 (0.253–24.121) | 0.436 |
| Stage‐TMN | 46 | ||||
| >Stage II | 28 | Reference | Reference | ||
| ≤Stage II | 18 | 0.284 (0.113–0.715) | 0.008 | 0.055 (0.004–0.776) | 0.032 |
| YARS1 | 46 | 1.237 (1.064–1.440) | 0.006 | 1.489 (1.209–1.834) | <0.001 |
Note: The table highlights p value <0.05 in bold, indicating significant differences between groups.